Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights – Novartis (NYSE:NVS)
On Tuesday, Novartis AG NVS reported third-quarter sales of $12.823 billion, up 9% (+10% on constant currency), beating the consensus of $12.76 billion. Guidance: Novartis also raised its 2024 full-year…